MacCollin M, Willett C, Heinrich B, Jacoby L B, Acierno J S, Perry A, Louis D N
Department of Neurology, Massachusetts General Hospital, Charlestown, USA.
Neurology. 2003 Jun 24;60(12):1968-74. doi: 10.1212/01.wnl.0000070184.08740.e0.
Schwannomatosis is a recently recognized disorder, defined as multiple pathologically proven schwannomas without vestibular tumors diagnostic of neurofibromatosis 2 (NF2). Some investigators have questioned whether schwannomatosis is merely an attenuated form of NF2.
The authors identified eight families in which a proband met their diagnostic criteria for schwannomatosis. Archived and prospectively acquired tumor specimens were studied by mutational analysis at the NF2 locus, loss of heterozygosity analysis along chromosome 22, and fluorescent in situ hybridization analysis of NF2 and the more centromeric probe BCR. Linkage analysis could be performed in six of eight families.
Clinical characterization of these kindreds showed that no affected family member harbored a vestibular tumor. Molecular analysis of 28 tumor specimens from 17 affected individuals in these kindreds revealed a pattern of somatic NF2 inactivation incompatible with our current understanding of NF2 as an inherited tumor suppressor gene syndrome. Linkage analysis excluded the NF2 locus in two kindreds, and showed a maximum lod score of 6.60 near the more centromeric marker D22S1174.
Schwannomatosis shows clinical and molecular differences from NF2 and should be considered a third major form of neurofibromatosis. Further work is needed to identify the inherited genetic element responsible for familial schwannomatosis.
神经鞘瘤病是一种最近才被认识的疾病,定义为多个经病理证实的神经鞘瘤,且无诊断为2型神经纤维瘤病(NF2)的前庭肿瘤。一些研究者质疑神经鞘瘤病是否仅仅是NF2的一种轻型形式。
作者鉴定出8个家系,其中先证者符合他们的神经鞘瘤病诊断标准。对存档的和前瞻性获取的肿瘤标本进行NF2基因座的突变分析、22号染色体杂合性缺失分析以及NF2和更靠近着丝粒的探针BCR的荧光原位杂交分析。8个家系中有6个可进行连锁分析。
这些家系的临床特征显示,没有患病家庭成员患有前庭肿瘤。对这些家系中17名患病个体的28个肿瘤标本进行分子分析,发现体细胞NF2失活模式与我们目前对NF2作为一种遗传性肿瘤抑制基因综合征的理解不相符。连锁分析在2个家系中排除了NF2基因座,并在更靠近着丝粒的标记D22S1174附近显示出最大对数优势分数为6.60。
神经鞘瘤病在临床和分子方面与NF2存在差异,应被视为神经纤维瘤病的第三种主要形式。需要进一步开展工作来确定导致家族性神经鞘瘤病的遗传因素。